Resolve Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Resolve Therapeutics General Information

Description

Operator of a biotechnology company intended to help clients develop biologic therapies in clinical development for autoimmune diseases. The company specializes in developing new treatments for systemic lupus erythematosus and Sjogren's syndrome, enabling patients to find immediate treatment for such diseases and live a healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1951 NorthWest 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (208)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1951 NorthWest 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (208)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resolve Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC (Series B3) 02-Jan-2018 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series B2) 01-Oct-2016 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B1) 01-Nov-2012 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 13-May-2011 $2M $2M Completed Clinical Trials - Phase 2
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Resolve Therapeutics’s complete valuation and funding history, request access »

Resolve Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to help clients develop biologic therapies in clinical development for auto
Drug Discovery
Miami, FL
25 As of 2022

South San Francisco, CA
 

Foster City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resolve Therapeutics Competitors (7)

One of Resolve Therapeutics’s 7 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Gilead Formerly VC-backed Foster City, CA
Merck & Co. Corporation Rahway, NJ
Bristol-Myers Squibb Corporation Princeton, NJ
Amgen Formerly PE-Backed Thousand Oaks, CA
You’re viewing 5 of 7 competitors. Get the full list »

Resolve Therapeutics Patents

Resolve Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025147696-A1 Treatment of symptoms associated with sars-cov viral infection or a prior sars-cov viral infection with nuclease agents Inactive 05-Jan-2024
CA-3165342-A1 Treatment of sjogren's syndrome with nuclease fusion proteins Pending 29-Jun-2020
EP-4171614-A1 Treatment of sjogren's syndrome with nuclease fusion proteins Inactive 29-Jun-2020
WO-2022006153-A1 Treatment of sjogren's syndrome with nuclease fusion proteins Inactive 29-Jun-2020
US-20230355722-A1 Treatment of sjogren’s syndrome with nuclease fusion proteins Pending 29-Jun-2020 A61K38/465
To view Resolve Therapeutics’s complete patent history, request access »

Resolve Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resolve Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Washington University
To view Resolve Therapeutics’s complete investors history, request access »

Resolve Therapeutics FAQs

  • When was Resolve Therapeutics founded?

    Resolve Therapeutics was founded in 2010.

  • Where is Resolve Therapeutics headquartered?

    Resolve Therapeutics is headquartered in Miami, FL.

  • What is the size of Resolve Therapeutics?

    Resolve Therapeutics has 25 total employees.

  • What industry is Resolve Therapeutics in?

    Resolve Therapeutics’s primary industry is Drug Discovery.

  • Is Resolve Therapeutics a private or public company?

    Resolve Therapeutics is a Private company.

  • What is Resolve Therapeutics’s current revenue?

    The current revenue for Resolve Therapeutics is .

  • How much funding has Resolve Therapeutics raised over time?

    Resolve Therapeutics has raised $36.8M.

  • Who are Resolve Therapeutics’s investors?

    University of Washington has invested in Resolve Therapeutics.

  • Who are Resolve Therapeutics’s competitors?

    Genentech, Gilead, Merck & Co., Bristol-Myers Squibb, and Amgen are some of the 7 competitors of Resolve Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process